Search Results 911-920 of 18578 for Prednisone

1. Rovalpituzumab Tesirine in Delta-Like Protein 3-Expressing Advanced Solid Tumors - Mayo Clinic

   Systemic therapy with corticosteroids at >20 mg/day prednisone or equivalent within 1 week prior to the first dose of study drug. History of another ...

2. A Study of AO-176 as Monotherapy Combinated with Bortezomib and Dexamethasone in Adults with Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Use of systemic corticosteroids (> 10 mg prednisone or equivalent) within 15 days (except for prophylaxis for radiodiagnostic contrast reactions), or other ...

3. A Study to Perform Synovial Biopsies on Patients with Rheumatoid Arthritis - Mayo Clinic

   Prednisone or equivalent > 10 mg daily; Exclusion criteria are the same for controls. Participating Mayo Clinic locations. Study statuses change often. Please ...

4. Study to Evaluate the Safety, Tolerability and Preliminary Antitumor Activity of INCB059872 in Patients with Relapsed/Refractory Ewing Sarcoma - Mayo Clinic

   ... (prednisone ≤ 10 mg/day is allowed). Participants with laboratory values at screening, without transfusions and hematopoietic growth factor support, defined ...

5. Obesity Treatment Outcomes in Liver Transplant Recipients - Mayo Clinic

   Chronic prednisone > 5mg/day. Concurrent opportunistic infections. Pregnancy. Gastrointestinal bleeding refractory to medical/endoscopic treatment ...

6. Elevate CLL R/R: Study of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Subjects With High Risk Chronic Lymphocytic Leukemia - Mayo Clinic

   ... prednisone daily or equivalent). Prior exposure to ibrutinib or to a B-cell receptor (BCR) inhibitor (e.g., Bruton tyrosine kinase [Btk] inhibitors or ...

7. Research forges path to effective treatment for sclerosing mesenteritis

   ... prednisone, which has the effect of easing pain by settling inflammation or causing scars to regress. Surgery to remove obstructions or growths is another ...

8. Phase III Study of DCVAC Added to Standard Chemotherapy for Men with Metastatic Castration Resistant Prostate Cancer - Mayo Clinic

   Subjects who are not indicated for chemotherapy treatment with first line Standard of Care chemotherapy (docetaxel and prednisone); Systemic corticosteroids ...

9. AKT Inhibitor MK2206, Combined with Bendamustine Hydrochloride, and Rituximab for Treating Patients who have Relapsed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma - Mayo Clinic

   EXCEPTION: low doses of steroids (< 10 mg of prednisone or equivalent dose of other steroid) used for treatment of non-hematologic medical conditions ...

10. 5-strain Probiotic Formulation in Hormone Receptor-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss - Mayo Clinic

    Immunocompromised patients including patients known to be HIV positive or those on chronic steroids > 20 mg prednisone a day or prednisone-equivalent. Note ...